Considering the beneficial effects of stevia in metabolic disorders and diabetes, the stevia-mediated reduction of hsCRP and ESR observed in the current study among CKD patients may suggest a potential interaction with PFKFB-3. The gene discussed is PFKFB3; the disease is metabolic disease.